Latin
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Xiubao Ren

Director Centri Investigationis Transformationis Immunotherapiae et dux Departamenti Scientiae Immunotherapiae pro Tumoribus
Medicus princeps, professor, doctor medicinae, supervisor doctoralis
Vicepraeses et Secretarius Generalis Commissionis Professionalis Applicationis Clinicae Societatis Sinensis Biotechnologiae Medicae
Societas et sodalis consilii Societatis Anti-Cancri Tianjinensis
Sodalis perpetuus Commissionis Professionalis Cancri Pulmonis et Commissionis Professionalis Rehabilitationis et Curationis Palliativae Societatis Anti-Cancri Tianjinensis
Director Vicarius Centri Diagnosis et Curationis Cancri Pulmonis Tianjinensis

Introductio Periti:

In investigatione clinica et fundamentali immunotherapiae tumoris, insignia progressa sunt, praesertim in organica coniunctione chemotherapiae conventionalis cum technologiis modernis curationis biologicae (velut therapia vaccinorum tumoris, therapia cellularum CIK, therapia medicamentorum moleculariter directa, et immunotherapia transplantationis cellularum haematopoieticarum primordialium allogeneica). Hoc paulatim novum exemplar therapiae tumoris biologicae personalizatae formavit, quod "chemotherapia ad malum eliminandum, immunotherapia ad fundamentum consolidandum" insignitur.

Duodecim